About MGI Tech
MGI Tech is a company based in Shenzhen (China) founded in 2016. It operates as a HealthTech and Professional Services. MGI Tech has raised $1 billion across 2 funding rounds from investors including Guotai Junan Securities, IDG Capital and CPE. MGI Tech offers products and services including T1+ Sequencer, DNBSEQ™ Technology, and Stereo-seq Spatio-temporal Omics. MGI Tech operates in a competitive market with competitors including Arbor Biotechnologies, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.
- Headquarter Shenzhen, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Shenzhen Mgi Tech Co., Ltd.
-
Annual Revenue
$409.62 M (USD)3.53as on Dec 31, 2024
-
Net Profit
-$82.31 M (USD)1.1as on Dec 31, 2024
-
EBITDA
-$27.45 M (USD)59.69as on Dec 31, 2024
-
Total Equity Funding
$1 B (USD)
in 2 rounds
-
Latest Funding Round
$1 B (USD), Series B
May 28, 2020
-
Investors
Guotai Junan Securities
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MGI Tech
MGI Tech offers a comprehensive portfolio of products and services, including T1+ Sequencer, DNBSEQ™ Technology, and Stereo-seq Spatio-temporal Omics.
Desktop sequencer achieving Tb-level sequencing in 24 hours.
Core technology used for high-throughput genetic sequencing applications.
Tool for spatial gene expression analysis in tissues.
Funding Insights of MGI Tech
MGI Tech has successfully raised a total of $1B across 2 strategic funding rounds. The most recent funding activity was a Series B round of $1 billion completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MGI Tech
MGI Tech has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Guotai Junan Securities, IDG Capital and CPE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm
|
Locked | Locked | Locked | |
|
Acquisitions are targeted by CPE as a private equity firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for MGI Tech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MGI Tech
Investment portfolio details for MGI Tech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MGI Tech
Detailed financials for MGI Tech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mgi Tech Comparisons
Peer comparison for MGI Tech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MGI Tech
MGI Tech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arbor Biotechnologies, Quanterix, Biocare Medical, Merck and BioLife Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic technologies and drug discovery platforms are provided.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
Detailed competitors of MGI Tech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mgi Tech
Complete news archive for MGI Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MGI Tech
MGI Tech was founded in 2016 and raised its 1st funding round 3 years after it was founded.
MGI Tech is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
MGI Tech is a funded company, having raised a total of $1B across 2 funding rounds to date.
Annual revenue of MGI Tech is $409.62M as on Dec 31, 2024.
MGI Tech is focused on the development and production of instruments, reagents, and consumables in the life sciences and biotechnology sectors. The company is dedicated to providing real-time, panoramic, and full-life-cycle digital life equipment and systems. Solutions are offered for precision medicine, precision agriculture, and precision health industries. Advanced sequencing platforms and omics technologies are developed to support research and applications in microbial genomics, public health, and environmental biodiversity. The company aims to be a core tool creator in life technology, driving innovation across multiple emerging fields.
MGI Tech's top competitors include Arbor Biotechnologies, Biocare Medical and Merck.
MGI Tech offers T1+ Sequencer, DNBSEQ™ Technology, and Stereo-seq Spatio-temporal Omics.
MGI Tech has 11 investors. Key investors include Guotai Junan Securities, IDG Capital, CPE, Huatai Zijin Investment, and Titanium Capital.